OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 36 citing articles:

Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy
Yutong Wang, Yiming Huo, Chunyuan Zhao, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 170-183
Closed Access | Times Cited: 27

The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control
Jinhai Deng, Teng Pan, Zaoqu Liu, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 12, pp. 1877-1892
Open Access | Times Cited: 24

Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production
Lyudmila V. Bel’skaya, Elena I. Dyachenko
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4646-4687
Open Access | Times Cited: 11

The Cancer Antioxidant Regulation System in Therapeutic Resistance
Xuanhao Gu, Chunyang Mu, Rujia Zheng, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 778-778
Open Access | Times Cited: 9

Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
Poonam N. Desai, Bofei Wang, André Fonseca, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 7, pp. 1011-1028
Open Access | Times Cited: 17

Understanding of chemotherapeutic resistance: With special reference to breast cancer
Harmanjit Singh, Dwividendra Kumar Nim, Pankaj Kumar, et al.
Elsevier eBooks (2025), pp. 173-206
Closed Access

Anti-miRNA therapeutics for uterine fibroids
Sharad Saxena, Maria Concetta Volpe, Chiara Agostinis, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117946-117946
Closed Access

Targeting the E2F1/Rb/HDAC1 axis with the small molecule HR488B effectively inhibits colorectal cancer growth
Namin Duan, Xiaohui Hu, Huiran Qiu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 11

Research progress on the role of reactive oxygen species in the initiation, development and treatment of breast cancer
Jing Zhong, Yan Tang
Progress in Biophysics and Molecular Biology (2024) Vol. 188, pp. 1-18
Closed Access | Times Cited: 4

Targeting Metabolic–Redox Nexus to Regulate Drug Resistance: From Mechanism to Tumor Therapy
Yuke Wang, Jingqiu He, Shan Lian, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 828-828
Open Access | Times Cited: 4

Co-exposure of avermectin and imidacloprid induces DNA damage, pyroptosis, and immune dysfunction in epithelioma papulosum cyprini cells via ROS-mediated Keap1/Nrf2/TXNIP axis
Huanyi Liu, Kun Wang, Dong‐Xu Han, et al.
Fish & Shellfish Immunology (2023) Vol. 140, pp. 108985-108985
Closed Access | Times Cited: 10

The dual role of ferroptosis in anthracycline-based chemotherapy includes reducing resistance and increasing toxicity
Jiazheng Zhao, Ning Zhang, Xiaowei Ma, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9

C-Myc Expression in Oral Squamous Cell Carcinoma: Molecular Mechanisms in Cell Survival and Cancer Progression
Guya Diletta Marconi, Ylenia Della Rocca, Luigia Fonticoli, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 890-890
Open Access | Times Cited: 14

Preparation of antioxidant-biodegradable poly(acrylic acid-co-2-hydroxyethyl methacrylate) hydrogel using rutin as a crosslinker: Drug release and anticancer activity
Ferah Cömert Önder, Alper Önder, Pınar Ilgın, et al.
Reactive and Functional Polymers (2023) Vol. 190, pp. 105650-105650
Closed Access | Times Cited: 8

Upregulation of p300 in paclitaxel-resistant TNBC: implications for cell proliferation via the PCK1/AMPK axis
Pengwei Zhao, Jiaxian Cui, X. Wang
The Pharmacogenomics Journal (2024) Vol. 24, Iss. 2
Closed Access | Times Cited: 2

Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer
Helena Muley, Karmele Valencia, Josefina Casas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 946-946
Open Access | Times Cited: 6

Histone methyltransferase inhibitor UNC0642 promotes breast cancer cell death by upregulating TXNIP-dependent oxidative stress
Jasvinder A. Singh, Bindeshwar Sah, Yao Shen, et al.
Chemico-Biological Interactions (2023) Vol. 385, pp. 110720-110720
Closed Access | Times Cited: 6

Synergistic approach to combat triple-negative breast cancer: Ti3C2/TiO2-based photothermal therapy combined with sonodynamic effect for tumor ablation
Hui Luo, Yongquan Huang, Zeyu Cai, et al.
Ceramics International (2023) Vol. 50, Iss. 4, pp. 6042-6054
Closed Access | Times Cited: 5

Self-assembled silibinin-containing phosphazene/cystamine hybrid nanospheres as biodagradable dual-drug carriers with improved anticancer activity on a breast cancer cell line
Fatma Ozsoy, Ferah Cömert Önder, Pınar Ilgın, et al.
Materials Today Communications (2023) Vol. 37, pp. 107116-107116
Closed Access | Times Cited: 4

Tubule-specific cyclin-dependent kinase 12 knockdown potentiates kidney injury through transcriptional elongation defects
Yilin Zhang, Tao‐Tao Tang, Wei‐Jie Ni, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1669-1687
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top